APO Research
Talk to an analyst

APO RESEARCH · REPORT

Furosemide Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Furosemide Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchFurosemide Injection Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Furosemide Injection Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Furosemide Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Furosemide Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Furosemide Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Furosemide Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Furosemide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Furosemide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Furosemide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Furosemide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Furosemide Injection include AuroMedics, Avet Pharmaceuticals, SteriMax, Baxter, Chengdu Brilliant Pharmaceutical, Fresenius Kabi, Hainan Huanglong Pharm, Hunan Kelun Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Furosemide Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Furosemide Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Furosemide Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Furosemide Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Furosemide Injection Segment by Company

AuroMedics

Avet Pharmaceuticals

SteriMax

Baxter

Chengdu Brilliant Pharmaceutical

Fresenius Kabi

Hainan Huanglong Pharm

Hunan Kelun Pharmaceutical

Pfizer

Shagnhai Harvest Pharamceutical

Shenyang Guagnda Pharm

CSPC Ouyi Pharm

Changbaishan Pharmaceutical

Furosemide Injection Segment by Type

40mg/40ml

20mg/2ml

100mg/10ml

Furosemide Injection Segment by Application

Recovery Center

Hospital

Clinics

Furosemide Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Furosemide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Furosemide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Furosemide Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Furosemide Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Furosemide Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Furosemide Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Furosemide Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Furosemide Injection Industry Trends Table 2. Furosemide Injection Industry Drivers Table 3. Furosemide Injection Industry Opportunities and Challenges Table 4. Furosemide Injection Industry Restraints Table 5. Global Furosemide Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Furosemide Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Furosemide Injection Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Furosemide Injection Sales Market Share by Manufacturers Table 9. Global Furosemide Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Furosemide Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Furosemide Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Furosemide Injection Manufacturers, Product Type & Application Table 13. Global Furosemide Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Furosemide Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 40mg/40ml Table 17. Major Manufacturers of 20mg/2ml Table 18. Major Manufacturers of 100mg/10ml Table 19. Global Furosemide Injection Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Furosemide Injection Sales by Type (2021-2026) & (W Units) Table 21. Global Furosemide Injection Sales by Type (2027-2032) & (W Units) Table 22. Global Furosemide Injection Sales Market Share by Type (2021-2026) Table 23. Global Furosemide Injection Sales Market Share by Type (2027-2032) Table 24. Global Furosemide Injection Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 25. Global Furosemide Injection Revenue by Type (2021-2026) & (W Units) Table 26. Global Furosemide Injection Revenue by Type (2027-2032) & (W Units) Table 27. Global Furosemide Injection Revenue Market Share by Type (2021-2026) Table 28. Global Furosemide Injection Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Recovery Center Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinics Table 32. Global Furosemide Injection Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Furosemide Injection Sales by Application (2021-2026) & (W Units) Table 34. Global Furosemide Injection Sales by Application (2027-2032) & (W Units) Table 35. Global Furosemide Injection Sales Market Share by Application (2021-2026) Table 36. Global Furosemide Injection Sales Market Share by Application (2027-2032) Table 37. Global Furosemide Injection Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Furosemide Injection Revenue by Application (2021-2026) & (W Units) Table 39. Global Furosemide Injection Revenue by Application (2027-2032) & (W Units) Table 40. Global Furosemide Injection Revenue Market Share by Application (2021-2026) Table 41. Global Furosemide Injection Revenue Market Share by Application (2027-2032) Table 42. Global Furosemide Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Furosemide Injection Sales by Region (2021-2026) & (W Units) Table 44. Global Furosemide Injection Sales Market Share by Region (2021-2026) Table 45. Global Furosemide Injection Sales Forecasted by Region (2027-2032) & (W Units) Table 46. Global Furosemide Injection Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Furosemide Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 48. North America Furosemide Injection Sales by Country (2021-2026) & (W Units) Table 49. North America Furosemide Injection Sales by Country (2027-2032) & (W Units) Table 50. Europe Furosemide Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 51. Europe Furosemide Injection Sales by Country (2021-2026) & (W Units) Table 52. Europe Furosemide Injection Sales by Country (2027-2032) & (W Units) Table 53. Asia Pacific Furosemide Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Asia Pacific Furosemide Injection Sales by Country (2021-2026) & (W Units) Table 55. Asia Pacific Furosemide Injection Sales by Country (2027-2032) & (W Units) Table 56. South America, Middle East and Africa Furosemide Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. South America, Middle East and Africa Furosemide Injection Sales by Country (2021-2026) & (W Units) Table 58. South America, Middle East and Africa Furosemide Injection Sales by Country (2027-2032) & (W Units) Table 59. Global Furosemide Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Furosemide Injection Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Furosemide Injection Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Furosemide Injection Revenue Market Share by Region (2021-2026) Table 63. Global Furosemide Injection Revenue Market Share by Region (2027-2032) Table 64. AuroMedics Company Information Table 65. AuroMedics Business Overview Table 66. AuroMedics Furosemide Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. AuroMedics Furosemide Injection Product Portfolio Table 68. AuroMedics Recent Development Table 69. Avet Pharmaceuticals Company Information Table 70. Avet Pharmaceuticals Business Overview Table 71. Avet Pharmaceuticals Furosemide Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Avet Pharmaceuticals Furosemide Injection Product Portfolio Table 73. Avet Pharmaceuticals Recent Development Table 74. SteriMax Company Information Table 75. SteriMax Business Overview Table 76. SteriMax Furosemide Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. SteriMax Furosemide Injection Product Portfolio Table 78. SteriMax Recent Development Table 79. Baxter Company Information Table 80. Baxter Business Overview Table 81. Baxter Furosemide Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Baxter Furosemide Injection Product Portfolio Table 83. Baxter Recent Development Table 84. Chengdu Brilliant Pharmaceutical Company Information Table 85. Chengdu Brilliant Pharmaceutical Business Overview Table 86. Chengdu Brilliant Pharmaceutical Furosemide Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Chengdu Brilliant Pharmaceutical Furosemide Injection Product Portfolio Table 88. Chengdu Brilliant Pharmaceutical Recent Development Table 89. Fresenius Kabi Company Information Table 90. Fresenius Kabi Business Overview Table 91. Fresenius Kabi Furosemide Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Fresenius Kabi Furosemide Injection Product Portfolio Table 93. Fresenius Kabi Recent Development Table 94. Hainan Huanglong Pharm Company Information Table 95. Hainan Huanglong Pharm Business Overview Table 96. Hainan Huanglong Pharm Furosemide Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Hainan Huanglong Pharm Furosemide Injection Product Portfolio Table 98. Hainan Huanglong Pharm Recent Development Table 99. Hunan Kelun Pharmaceutical Company Information Table 100. Hunan Kelun Pharmaceutical Business Overview Table 101. Hunan Kelun Pharmaceutical Furosemide Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Hunan Kelun Pharmaceutical Furosemide Injection Product Portfolio Table 103. Hunan Kelun Pharmaceutical Recent Development Table 104. Pfizer Company Information Table 105. Pfizer Business Overview Table 106. Pfizer Furosemide Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Pfizer Furosemide Injection Product Portfolio Table 108. Pfizer Recent Development Table 109. Shagnhai Harvest Pharamceutical Company Information Table 110. Shagnhai Harvest Pharamceutical Business Overview Table 111. Shagnhai Harvest Pharamceutical Furosemide Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Shagnhai Harvest Pharamceutical Furosemide Injection Product Portfolio Table 113. Shagnhai Harvest Pharamceutical Recent Development Table 114. Shenyang Guagnda Pharm Company Information Table 115. Shenyang Guagnda Pharm Business Overview Table 116. Shenyang Guagnda Pharm Furosemide Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Shenyang Guagnda Pharm Furosemide Injection Product Portfolio Table 118. Shenyang Guagnda Pharm Recent Development Table 119. CSPC Ouyi Pharm Company Information Table 120. CSPC Ouyi Pharm Business Overview Table 121. CSPC Ouyi Pharm Furosemide Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. CSPC Ouyi Pharm Furosemide Injection Product Portfolio Table 123. CSPC Ouyi Pharm Recent Development Table 124. Changbaishan Pharmaceutical Company Information Table 125. Changbaishan Pharmaceutical Business Overview Table 126. Changbaishan Pharmaceutical Furosemide Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Changbaishan Pharmaceutical Furosemide Injection Product Portfolio Table 128. Changbaishan Pharmaceutical Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Furosemide Injection Distributors List Table 132. Furosemide Injection Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Furosemide Injection Product Image Figure 2. Global Furosemide Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Furosemide Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Furosemide Injection Sales (2021-2032) & (W Units) Figure 5. Global Furosemide Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Furosemide Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 40mg/40ml Image Figure 9. 20mg/2ml Image Figure 10. 100mg/10ml Image Figure 11. Global Furosemide Injection Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Furosemide Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Furosemide Injection Sales Market Share by Type (2021-2032) Figure 14. Global Furosemide Injection Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Furosemide Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Furosemide Injection Revenue Market Share by Type (2021-2032) Figure 17. Recovery Center Image Figure 18. Hospital Image Figure 19. Clinics Image Figure 20. Global Furosemide Injection Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Furosemide Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Furosemide Injection Sales Market Share by Application (2021-2032) Figure 23. Global Furosemide Injection Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Furosemide Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Furosemide Injection Revenue Market Share by Application (2021-2032) Figure 26. North America Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 27. North America Furosemide Injection Sales Market Share by Country (2021-2032) Figure 28. U.S. Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Canada Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Mexico Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Furosemide Injection Sales Market Share by Country (2021-2032) Figure 33. Germany Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 34. France Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 35. U.K. Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Italy Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Netherlands Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Furosemide Injection Sales Market Share by Country (2021-2032) Figure 40. China Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Japan Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 42. South Korea Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Southeast Asia Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 44. India Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Australia Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Furosemide Injection Sales Market Share by Country (2021-2032) Figure 48. Brazil Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South Africa Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Saudi Arabia Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Turkey Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Argentina Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 53. UAE Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Egypt Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Chile Furosemide Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Global Furosemide Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Furosemide Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Furosemide Injection Revenue (2021-2032) & (US$ Million) Figure 59. North America Furosemide Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Furosemide Injection Revenue (2021-2032) & (US$ Million) Figure 61. Europe Furosemide Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Furosemide Injection Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Furosemide Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Furosemide Injection Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Furosemide Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Furosemide Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Furosemide Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg/40ml
  • 20mg/2ml
  • 100mg/10ml
Applications
  • Recovery Center
  • Hospital
  • Clinics
Companies covered
  • AuroMedics
  • Avet Pharmaceuticals
  • SteriMax
  • Baxter
  • Chengdu Brilliant Pharmaceutical
  • Fresenius Kabi
  • Hainan Huanglong Pharm
  • Hunan Kelun Pharmaceutical
  • Pfizer
  • Shagnhai Harvest Pharamceutical
  • Shenyang Guagnda Pharm
  • CSPC Ouyi Pharm
  • Changbaishan Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Furosemide Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Furosemide Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Furosemide Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Furosemide Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Furosemide Injection Market Dynamics
  1. 2.1 Furosemide Injection Industry Trends
  2. 2.2 Furosemide Injection Industry Drivers
  3. 2.3 Furosemide Injection Industry Opportunities and Challenges
  4. 2.4 Furosemide Injection Industry Restraints
3 Furosemide Injection Market by Manufacturers
  1. 3.1 Global Furosemide Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Furosemide Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Furosemide Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Furosemide Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Furosemide Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Furosemide Injection Manufacturers, Product Type & Application
  7. 3.7 Global Furosemide Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Furosemide Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Furosemide Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Furosemide Injection Tier 1, Tier 2, and Tier 3
4 Furosemide Injection Market by Type
  1. 4.1 Furosemide Injection Type Introduction
  2. 4.1.1 40mg/40ml
  3. 4.1.2 20mg/2ml
  4. 4.1.3 100mg/10ml
  5. 4.2 Global Furosemide Injection Sales by Type
  6. 4.2.1 Global Furosemide Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Furosemide Injection Sales by Type (2021-2032)
  8. 4.2.3 Global Furosemide Injection Sales Market Share by Type (2021-2032)
  9. 4.3 Global Furosemide Injection Revenue by Type
  10. 4.3.1 Global Furosemide Injection Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Furosemide Injection Revenue by Type (2021-2032)
  12. 4.3.3 Global Furosemide Injection Revenue Market Share by Type (2021-2032)
5 Furosemide Injection Market by Application
  1. 5.1 Furosemide Injection Application Introduction
  2. 5.1.1 Recovery Center
  3. 5.1.2 Hospital
  4. 5.1.3 Clinics
  5. 5.2 Global Furosemide Injection Sales by Application
  6. 5.2.1 Global Furosemide Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Furosemide Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Furosemide Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Furosemide Injection Revenue by Application
  10. 5.3.1 Global Furosemide Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Furosemide Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Furosemide Injection Revenue Market Share by Application (2021-2032)
6 Global Furosemide Injection Sales by Region
  1. 6.1 Global Furosemide Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Furosemide Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Furosemide Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Furosemide Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Furosemide Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Furosemide Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Furosemide Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Furosemide Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Furosemide Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Furosemide Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Furosemide Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Furosemide Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Furosemide Injection Revenue by Region
  1. 7.1 Global Furosemide Injection Revenue by Region
  2. 7.1.1 Global Furosemide Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Furosemide Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Furosemide Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Furosemide Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Furosemide Injection Revenue (2021-2032)
  8. 7.2.2 North America Furosemide Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Furosemide Injection Revenue (2021-2032)
  11. 7.3.2 Europe Furosemide Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Furosemide Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Furosemide Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Furosemide Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Furosemide Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AuroMedics
  2. 8.1.1 AuroMedics Company Information
  3. 8.1.2 AuroMedics Business Overview
  4. 8.1.3 AuroMedics Furosemide Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AuroMedics Furosemide Injection Product Portfolio
  6. 8.1.5 AuroMedics Recent Developments
  7. 8.2 Avet Pharmaceuticals
  8. 8.2.1 Avet Pharmaceuticals Company Information
  9. 8.2.2 Avet Pharmaceuticals Business Overview
  10. 8.2.3 Avet Pharmaceuticals Furosemide Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Avet Pharmaceuticals Furosemide Injection Product Portfolio
  12. 8.2.5 Avet Pharmaceuticals Recent Developments
  13. 8.3 SteriMax
  14. 8.3.1 SteriMax Company Information
  15. 8.3.2 SteriMax Business Overview
  16. 8.3.3 SteriMax Furosemide Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SteriMax Furosemide Injection Product Portfolio
  18. 8.3.5 SteriMax Recent Developments
  19. 8.4 Baxter
  20. 8.4.1 Baxter Company Information
  21. 8.4.2 Baxter Business Overview
  22. 8.4.3 Baxter Furosemide Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Baxter Furosemide Injection Product Portfolio
  24. 8.4.5 Baxter Recent Developments
  25. 8.5 Chengdu Brilliant Pharmaceutical
  26. 8.5.1 Chengdu Brilliant Pharmaceutical Company Information
  27. 8.5.2 Chengdu Brilliant Pharmaceutical Business Overview
  28. 8.5.3 Chengdu Brilliant Pharmaceutical Furosemide Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Chengdu Brilliant Pharmaceutical Furosemide Injection Product Portfolio
  30. 8.5.5 Chengdu Brilliant Pharmaceutical Recent Developments
  31. 8.6 Fresenius Kabi
  32. 8.6.1 Fresenius Kabi Company Information
  33. 8.6.2 Fresenius Kabi Business Overview
  34. 8.6.3 Fresenius Kabi Furosemide Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fresenius Kabi Furosemide Injection Product Portfolio
  36. 8.6.5 Fresenius Kabi Recent Developments
  37. 8.7 Hainan Huanglong Pharm
  38. 8.7.1 Hainan Huanglong Pharm Company Information
  39. 8.7.2 Hainan Huanglong Pharm Business Overview
  40. 8.7.3 Hainan Huanglong Pharm Furosemide Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hainan Huanglong Pharm Furosemide Injection Product Portfolio
  42. 8.7.5 Hainan Huanglong Pharm Recent Developments
  43. 8.8 Hunan Kelun Pharmaceutical
  44. 8.8.1 Hunan Kelun Pharmaceutical Company Information
  45. 8.8.2 Hunan Kelun Pharmaceutical Business Overview
  46. 8.8.3 Hunan Kelun Pharmaceutical Furosemide Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hunan Kelun Pharmaceutical Furosemide Injection Product Portfolio
  48. 8.8.5 Hunan Kelun Pharmaceutical Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Furosemide Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Furosemide Injection Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Shagnhai Harvest Pharamceutical
  56. 8.10.1 Shagnhai Harvest Pharamceutical Company Information
  57. 8.10.2 Shagnhai Harvest Pharamceutical Business Overview
  58. 8.10.3 Shagnhai Harvest Pharamceutical Furosemide Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shagnhai Harvest Pharamceutical Furosemide Injection Product Portfolio
  60. 8.10.5 Shagnhai Harvest Pharamceutical Recent Developments
  61. 8.11 Shenyang Guagnda Pharm
  62. 8.11.1 Shenyang Guagnda Pharm Company Information
  63. 8.11.2 Shenyang Guagnda Pharm Business Overview
  64. 8.11.3 Shenyang Guagnda Pharm Furosemide Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shenyang Guagnda Pharm Furosemide Injection Product Portfolio
  66. 8.11.5 Shenyang Guagnda Pharm Recent Developments
  67. 8.12 CSPC Ouyi Pharm
  68. 8.12.1 CSPC Ouyi Pharm Company Information
  69. 8.12.2 CSPC Ouyi Pharm Business Overview
  70. 8.12.3 CSPC Ouyi Pharm Furosemide Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CSPC Ouyi Pharm Furosemide Injection Product Portfolio
  72. 8.12.5 CSPC Ouyi Pharm Recent Developments
  73. 8.13 Changbaishan Pharmaceutical
  74. 8.13.1 Changbaishan Pharmaceutical Company Information
  75. 8.13.2 Changbaishan Pharmaceutical Business Overview
  76. 8.13.3 Changbaishan Pharmaceutical Furosemide Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Changbaishan Pharmaceutical Furosemide Injection Product Portfolio
  78. 8.13.5 Changbaishan Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Furosemide Injection Value Chain Analysis
  2. 9.1.1 Furosemide Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Furosemide Injection Production Mode & Process
  6. 9.2 Furosemide Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Furosemide Injection Distributors
  9. 9.2.3 Furosemide Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst